← SynDRA
BUTENAFINE
SynDRA canonical compound SYN0002981 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | SQLE |
| Mechanism of action | fungal squalene epoxidase inhibitor |
| Indication | tinea corporis | tinea cruris | tinea pedis |
| Disease area | infectious disease |
All known targets
- ACHE
- ADRA2A
- CYP2D6
- Candi ERG1
- ERG1
- Pgrmc1
- SIGMAR1
- SLC6A2
- SLC6A4
- SQLE
- fabI
Mechanisms of action (all sources)
- fungal squalene epoxidase inhibitor
- Candi ERG1 MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADORA1
- NPY2R
- MMP9
- MMP1
- MLNR
- MC5R
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAPK1
- MAOA
- LMNA
- LCK
- HTR6
- HTR3A
- HTR2C
- HTR2B
- HTR2A
- HTR1A
- HRH3
- HRH2
- HRH1
- HMGCR
- HDAC6
- NPY1R
- NR1I2
- ADORA2A
- NR3C1
- USP1
- TDP1
- TBXAS1
- TBXA2R
- TACR2
- TACR1
- SLC6A3
- SLC29A1
- SAMHD1
- PTPRC
- PTGS2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Anti-Infective Agents
- Antifungal Agents
- Benzylamine Antifungal
ATC classes
- D01A · ANTIFUNGALS FOR TOPICAL USE
Cross-references
Synonyms
- BUTENAFINE HYDROCHLORIDE
- LOTRIMIN ULTRA
- MENTAX
- MENTAX-TC
- Mentax
- KP 363
- butenafine hydrochloride
- butenafine HCl
- Butenafina
- Butenafinum
- Butenafine HCL
- Butenafine [INN]
- Butenafine hydrochloride
- KP-363
- Butenafina [INN-Spanish]
- Butenafine (INN)
- Butenafinum [INN-Latin]
- Butop (TN)
- Mentax (TN)
- N-p-tert-Butylbenzyl-N-methyl-1-naphthalenemethylamine
- N-(p-tert-Butylbenzyl)-N-methyl-1-naphthalenemethylamine
- 4-tert-butylbenzyl(methyl)(1-naphthalenemethyl)amine
- CHEBI:3238
- DTXCID5020657
- (4-tert-Butyl-benzyl)-methyl-naphthalen-1-ylmethyl-amine
- RefChem:54581
- D01AE23
- NCGC00159511-02
- CAS-101828-21-1
- MFCD00917064
- C23H27N
- Butenafine [INN:BAN]
- SR-05000001448
- UNII-91Y494NL0X
- Spectrum_001553
- BUTENAFINE [MI]
- SpecPlus_000920
- BUTENAFINE [VANDF]
Look up BUTENAFINE in the interactive SynDRA portal →